Literature DB >> 22579918

Sustained expression of heme oxygenase-1 alters iron homeostasis in nonerythroid cells.

Cheng Li1, Maria E Lönn, Xiangcong Xu, Ghassan J Maghzal, David M Frazer, Shane R Thomas, Barry Halliwell, Des R Richardson, Gregory J Anderson, Roland Stocker.   

Abstract

Heme oxygenases initiate the catabolism of heme, releasing carbon monoxide, iron, and biliverdin. Sustained induction of heme oxygenase-1 (HO-1) in nonerythroid cells plays a key role in many pathological processes, yet the effect of long-term HO-1 expression on cellular iron metabolism in the absence of exogenous heme is poorly understood. Here we report that in a model nonerythroid cell, both transient and stable HO-1 expression increased heme oxygenase activity, but total cellular heme content was decreased only with transient enzyme expression. Sustained HO-1 activity increased the expression of both the mitochondrial iron importer mitoferrin-2 and the rate-limiting enzyme in heme synthesis, aminolevulinate synthase-1, and it augmented the mitochondrial content of heme. Also, the expression of transferrin receptor-1 and the activities of iron-regulatory proteins 1 and 2 decreased, whereas total labile iron and the regulatory activity of the heme-binding transcription factor Bach1 were unaltered. In addition, stable, but not transient, HO-1 expression decreased the activities of aconitase, as well as increasing proteasomal degradation of ferritin. Together, our results reveal a novel and coordinated adaptive response of nonerythroid cells to sustained HO-1 induction that has an impact on cellular iron homeostasis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22579918     DOI: 10.1016/j.freeradbiomed.2012.03.007

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

1.  The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer.

Authors:  Izumi Yanatori; Des R Richardson; Shinya Toyokuni; Fumio Kishi
Journal:  J Biol Chem       Date:  2017-06-27       Impact factor: 5.157

2.  Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes.

Authors:  Dong-Hyun Kim; Hoon-In Choi; Jung Sun Park; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Redox Biol       Date:  2022-06-23       Impact factor: 10.787

3.  HO-1/EBP interaction alleviates cholesterol-induced hypoxia through the activation of the AKT and Nrf2/mTOR pathways and inhibition of carbohydrate metabolism in cardiomyocytes.

Authors:  Xiaohan Jin; Zhongwei Xu; Jin Cao; Rui Yan; Ruicheng Xu; Ruiqiong Ran; Yongqiang Ma; Wei Cai; Rong Fan; Yan Zhang; Xin Zhou; Yuming Li
Journal:  Int J Mol Med       Date:  2017-05-08       Impact factor: 4.101

Review 4.  Role of Heme Oxygenase as a Modulator of Heme-Mediated Pathways.

Authors:  J Catharina Duvigneau; Harald Esterbauer; Andrey V Kozlov
Journal:  Antioxidants (Basel)       Date:  2019-10-11

Review 5.  Heme Degradation in Pathophysiology of and Countermeasures to Inflammation-Associated Disease.

Authors:  Donald David Haines; Arpad Tosaki
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

6.  MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis.

Authors:  Hamed Alborzinia; Andrés F Flórez; Sina Kreth; Lena M Brückner; Umut Yildiz; Moritz Gartlgruber; Dorett I Odoni; Gernot Poschet; Karolina Garbowicz; Chunxuan Shao; Corinna Klein; Jasmin Meier; Petra Zeisberger; Michal Nadler-Holly; Matthias Ziehm; Franziska Paul; Jürgen Burhenne; Emma Bell; Marjan Shaikhkarami; Roberto Würth; Sabine A Stainczyk; Elisa M Wecht; Jochen Kreth; Michael Büttner; Naveed Ishaque; Matthias Schlesner; Barbara Nicke; Carlo Stresemann; María Llamazares-Prada; Jan H Reiling; Matthias Fischer; Ido Amit; Matthias Selbach; Carl Herrmann; Stefan Wölfl; Kai-Oliver Henrich; Thomas Höfer; Andreas Trumpp; Frank Westermann
Journal:  Nat Cancer       Date:  2022-04-28

7.  Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death.

Authors:  Min-Young Kwon; Eunhee Park; Seon-Jin Lee; Su Wol Chung
Journal:  Oncotarget       Date:  2015-09-15

8.  Dexmedetomidine alleviated sepsis‑induced myocardial ferroptosis and septic heart injury.

Authors:  Chunyan Wang; Wenlin Yuan; Anmin Hu; Juan Lin; Zhengyuan Xia; Catherine F Yang; Yalan Li; Zhongjun Zhang
Journal:  Mol Med Rep       Date:  2020-05-04       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.